Cord blood-derived CAR-NK cell therapy targeting TRBC1/2

· Second Affiliated Hospital, School of Medicine, Zhejiang University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cord blood-derived CAR-NK cell therapy targeting TRBC1/2, covering 2026-03-17 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: Exploratory Study of Umbilical Cord Blood-Derived CAR-NK Cell Therapy Targeting TRBC1/2 for Relapsed/Refractory T-Cell Lymphoma [Phase 1]

See pricing